In the autumn of 2020, a novel avian influenza virus was identified in Europe. The pathogen was classified as H5N1, clade 2.3.4.4b. Researchers traced its emergence to a period of genetic exchange rather than a sudden appearance.
Prior to 2020, from 2018 through 2020, two other highly pathogenic strains—H5N6 and H5N8—had been circulating widely among bird populations worldwide. These viruses were notable for their virulence and geographic reach.
During this time, the genetic material of H5N6 and H5N8 combined with additional avian influenza components through a process known as reassortment. The resulting virus retained the H5‑2.3.4.4b backbone from its predecessors but acquired new gene segments. This reassorted H5N1 strain carried the genetic legacy of the earlier viruses while exhibiting a broader host range and increased potential for adaptation.
The new clade 2.3.4.4b virus differed from earlier H5N1 variants in its ability to infect a wider array of species, including mammals. Such cross‑class infections are atypical for avian flu and signaled a shift in the virus’s biology.
As the pathogen moved into new hosts, it continued to undergo genetic reassortment with local influenza viruses, generating mutations that could alter transmissibility or pathogenicity. Each genetic swap represented a random trial; some changes had no effect, while others could produce variants with heightened fitness.
Global Spread and Consequences
Wild aquatic birds serve as the natural reservoir for the virus. They often carry the pathogen without showing illness, shedding infected feces into water and onto land during migration. Through this route, the virus can reach domestic poultry, mammals, and humans. Transmission occurs via close contact with contaminated droppings, exposure to infected material, or consumption of diseased birds.
Because migratory birds ignore political boundaries, the virus can disseminate rapidly across continents. By February 2025, the outbreak spanning 2020 to 2026 had reached every continent except Australia.
The pathogen’s adaptability to mammals raised concerns about further spillover events and the potential for sustained transmission in new hosts. Scientists closely monitor the ongoing genetic reassortment, recognizing that each replication cycle introduces variation that could either weaken the virus or enhance its ability to spread. The ramifications extend beyond animal health.
Outbreaks have triggered trade restrictions, mass culling of poultry, and economic losses for farmers and related industries. Livelihoods tied to poultry production and associated supply chains have been disrupted, illustrating how a pathogen originating in wildlife can affect global markets.
The situation underscores that the threat is not confined to farms; it is a systemic issue linked to the interconnectedness of ecosystems, trade, and human activity. Virologists describe the ongoing events as a prolonged process rather than an isolated incident. The initial groundwork laid by the prevalence of H5N6 and H5N8 enabled the emergence of the reassorted H5N1 clade 2.3.4.4b strain, which continues to evolve as it encounters new hosts and environments.
As long as wild birds migrate and the virus persists in reservoirs, opportunities for genetic exchange and adaptation remain, keeping researchers vigilant about future developments.
